IDEXX made pet test for COVID-19 Virus available to veterinarians
On Apr. 20, 2020, IDEXX Labs announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR Test for pets….
Rice University COVID-19 research fund awarded first grants
On Apr. 20, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it will support…
Biotechnology | Disease | FDA | Oncology | Therapeutics
FDA approved first new drug under international collaboration for patients with HER2-positive metastatic breast cancer
On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…
Roche developed new serology test to detect COVID-19 antibodies
On Apr. 17, 2020, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to…
Incyte announced initiation of phase 3 RUXCOVID study evaluating Ruxolitinib (Jakafi) as treatment for COVID-19 patients
On Apr. 17, 2020, Incyte announced the initiation of RUXCOVID, a global, randomized, double-blind, placebo-controlled phase 3 clinical…
Biotechnology | Disease | Influenza | Therapeutics | Vaccine
Celdara Medical entered into a CRADA with USAMRIID and the Geneva Foundation
On Apr. 17, 2020, Celdara Medical announced that it had entered into a Cooperative Research and Development Agreement…
Slower clearance of Coronavirus infection may explain why men fare worse than women
On Apr. 17, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved…
Biotechnology | Diagnostics | Disease | Neurology | NIH | Therapeutics
OHSU received more than $11 million to continue brain, cognitive development research
On Apr. 17, 2020, the National Institutes of Health (NIH) announced nearly $290 million of new funding for…
University of Washington blood test detected past infections with new coronavirus
On Apr. 17, 2020, the University of Washington Medicine announced that a new clinical blood test will be…
Mammoth Biosciences announced peer-reviewed validation of its rapid, CRISPR-based COVID-19 diagnostic
On Apr. 16, 2020, Mammoth Biosciences announced the publication of a study demonstrating the power of its platform…
Mayo Clinic prepared to commenced phase II FDA clinical trial for treatment of COVID-19 with Vicromax
On Apr. 16, 2020, BioSig Technologies announced that its subsidiary ViralClear Pharmaceuticals, had updated its clinical development program…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
Biogen, Broad Institute of MIT and Harvard, Partners HealthCare launched consortium to build and share a COVID-19 Biobank
On Apr. 16, 2020, Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare announced a consortium that…
Moderna announced BARDA award for up to $483 million to accelerate development of mRNA vaccine (mRNA-1273) against novel Coronavirus
On Apr. 16, 2020, Moderna announced an agreement for a commitment of up to $483 million from the…
Biogen, Broad Institute of MIT and Harvard, Partners HealthCare consortium build and share COVID-19 biobank
On Apr. 16, 2020, a team of researchers at the McGovern Institute for Brain Research at MIT, the…
OpGen subsidiary Ares Genetics demonstrated feasibility and next generation sequencing based antibiotic susceptibility testing in multi-center study
On Apr. 16, 2020, OpGen announced that a study on the feasibility and potential of antibiotic susceptibility testing…
Atossa Therapeutics launched COVID-19 HOPE drug development program
On Apr. 16, 2020, Atossa Therapeutics announced a new drug development program called COVID-19 HOPE. The program used…
U of A virology lab finds drug originally meant for Ebola effective against key enzyme of coronavirus that causes COVID-19
On Apr. 15, 2020, scientists at the University of Alberta have shown that the drug remdesivir is highly…
A gut-to-brain circuit drives sugar preference and may explain sugar cravings
On Apr. 15, 2020, Howard Hughes Medical Institute (HHMI) investigators report the sensation of sweetness starts on the…
Fujifilm accelerated production of its influenza antiviral drug ‘Avigan tablet’ for COVID-19
On Apr. 15, 2020, FUJIFILM announced that it had expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co.,…
Biotechnology | COVID-19 | Diagnostics | Medicine | Therapeutics | Vaccine
The Bill & Melinda Gates Foundation expands its commitment to global COVID-19 response
On Apr. 15, 2020, the Bill & Melinda Gates Foundation announced an expansion of its funding for the…
Philips teamed with University of Kentucky’s UK HealthCare to power state’s only eICU Clinical Command Center
On Apr. 15, 2020, Royal Philips and UK HealthCare, the clinical enterprise of the University of Kentucky, announced…
Penn Medicine launched national component of global registry to track exposures and outcomes among providers who intubate
On Apr. 15, 2020, a team at the Perelman School of Medicine at the University of Pennsylvania launched…
Singapore researchers use NanoString’s nCounter to rapidly profile response of immune system to SARS-CoV-2 virus
On Apr. 15, 2020, NanoString Technologies announced the first publication utilizing the nCounter platform and its leading gene…
Microneedle coronavirus vaccine triggered immune response in mice
On Apr. 14, 2020, researchers from the University of Pittsburgh announced that they had adapted a system to…
Sanofi and GSK announced an unprecedented vaccine collaboration to fight COVID-19
On Apr. 14, 2020, Sanofi and GSK announced that they had signed a letter of intent to enter…
Biotechnology | COVID-19 | Diagnostics | Genomics | Medicine | Therapeutics
Iceland provides picture of early spread of COVID-19 in population with cohesive public health response
On Apr. 14, 2020, scientists at deCODE genetics and Iceland’s Directorate of Health and the National University Hospital…
The Jackson Laboratory to provide expanded Coronavirus testing for Maine hospitals
On Apr. 14, 2020, the Jackson Laboratory (JAX) in collaboration with several Maine regional hospitals, announced additional coronavirus…
Alberta Hope COVID-19 study tested early treatment option
On Apr. 13, 2020, a province wide trial was announced by Alberta Hope that will investigate the effectiveness…
Biotechnology | Diagnostics | Neurology | NIH
NIH BRAIN Initiative tool helps researchers watch neural activity in 3D
On Apr. 13, 2020, an ultra-fast, 3D imaging technique called SCAPE microscopy, developed through the National Institutes of…
FDA approved first therapy for children with debilitating and disfiguring rare disease
On Apr. 13, 2020, the U.S. Food and Drug Administration (FDA) announced that given the increased demand for…